EMAIL THIS PAGE TO A FRIEND

Journal of Cancer Research and Clinical Oncology

Inhibition of 32Dp210 cells harboring T315I mutation by a novel derivative of emodin correlates with down-regulation of BCR-ABL and its downstream signaling pathways.


PMID 25217883

Abstract

We're sorry this abstract is currently not available.